High-dose continuous infusion beta-lactam antibiotics for the treatment of resistant Pseudomonas aeruginosa infections in immunocompromised patients.

High-dose continuous infusion beta-lactam antibiotics for the treatment of resistant Pseudomonas aeruginosa infections in immunocompromised patients.

Item
http://www.wikidata.org/entity/Q35141040
Current concepts in antimicrobial therapy against resistant gram-negative organisms: extended-spectrum beta-lactamase-producing Enterobacteriaceae, carbapenem-resistant Enterobacteriaceae, and multidrug-resistant Pseudomonas aeruginosaPharmacokinetic and pharmacodynamic issues for antimicrobial therapy in patients with cancerOsteomyelitis due to multiple carbapenemase-producing Gram-negative bacteria: The first case report of a GES-13-producing Pseudomonas aeruginosa isolate in Canada.Clinical management of aplastic anemia.β-lactam pharmacokinetics and pharmacodynamics in critically ill patients and strategies for dose optimization: a structured review.Continuous and extended infusions of β-lactam antibiotics in the pediatric population.Antimicrobial treatment of febrile neutropenia: pharmacokinetic-pharmacodynamic considerations.Antibiotic resistance in cancer patients.Optimizing Antibiotic Dosing Strategies for the Treatment of Gram-negative Infections in the Era of Resistance.Effect of meropenem administration in extended infusion on the clinical outcome of febrile neutropenia: a retrospective observational study.Antibiotic therapy in hematological neutropenic patients: what is the news?Probable Nonconvulsive Status Epilepticus With the Use of High-Dose Continuous Infusion Ceftazidime.Osteoarticular infection caused by MDR Pseudomonas aeruginosa: the benefits of combination therapy with colistin plus β-lactams.Pseudomonas bronchopulmonary infections in a palliative care setting.
P2860

High-dose continuous infusion beta-lactam antibiotics for the treatment of resistant Pseudomonas aeruginosa infections in immunocompromised patients.

Item
http://www.wikidata.org/entity/Q35141040
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
High-dose continuous infusion ...... in immunocompromised patients.
@ast
High-dose continuous infusion ...... in immunocompromised patients.
@en
type
label
High-dose continuous infusion ...... in immunocompromised patients.
@ast
High-dose continuous infusion ...... in immunocompromised patients.
@en
prefLabel
High-dose continuous infusion ...... in immunocompromised patients.
@ast
High-dose continuous infusion ...... in immunocompromised patients.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P932
P356
P1433
P1476
High-dose continuous infusion ...... in immunocompromised patients.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P932